Sorrento Therapeutics Inc (SRNE) is around the top of the Biotechnology industry according to InvestorsObserver. SRNE received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. Sorrento Therapeutics Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 33 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Sorrento Therapeutics Inc (SRNE) stock is flat 0% while the S&P 500 is unchanged 0% as of 9:34 AM on Monday, Nov 2. SRNE is unchanged $0.00 from the previous closing price of $6.94 on volume of 128,635 shares. Over the past year the S&P 500 is up 6.23% while SRNE is higher by 336.48%. SRNE lost -$1.61 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Sorrento Therapeutics Inc (SRNE) Stock.

Go here to see the original:
Is Sorrento Therapeutics Inc (SRNE) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver